Summary Bladders of anaesthetised mice were illuminated with laser light of 630 nm at 24 h after intraperitoneal administration of the photosensitiser Photofrin 11 (10 mg kg-'). A range of light doses, at a power setting of 100 mW, was delivered intravesically by a fibre optic inserted into the centre of the bladder via the urethra. Functional bladder damage was assessed from increases in urination frequency and the presence of haematuria at I to 26 weeks after treatment. Whole bladder illumination with incident light doses exceeding 18.75 J cm-2 caused extensive oedema, haemorrhage and necrosis of the bladder wall and mice had to be sacrificed within 24 h. PDT with incident light doses of 3.75 to 15.0 J cm 2 caused haematuria and increased urination frequency during the first week in nearly all mice, but there was complete functional recovery by 6 to 10 weeks after doses of up to 7.5 J cm-2. Recovery was slower after higher doses and up to 50% of mice still had some increased urination frequency at 10 weeks after > 11.25 J cm-2, although haematuria was rare at this time. Histologically, early damage (one day after PDT) consisted of epithelial sloughing, submucosal oedema, fibrin imbibition, vascular extasia and, rarely, thrombosis. Doses exceeding 7.5 J cm-2 were often associated with foci of necrosis. In some instances, necrosis was complicated by bacterial infection, resulting in an acute transmural inflammation with a tendency to suppuration. After doses of up to 11.25 J cm-2 there was a gradual recovery and only a mild degree of fibrosis of the bladder wall (with some increase in vascularity) remained at 6 months.
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Photodynamic therapy (PDT) is a promising alternative treatment for small superficial tumours in sites where adequate local surgery is difficult (e.g. obstructive lesions of the upper airways and multifocal bladder cancer). The basic principle of PDT consists of systemic administration of a photosensitising drug, followed by local illumination of the tumour with light of suitable wavelength to excite the sensitiser. In nearly all clinical trials performed to date, haematoporphyrin derivative (HPD), or the more purified Photofrin II, has been used as the photosensitiser in combination with laser light of 625-630nm delivered to the tumour site via optical fibres.
The haematoporphyrins are non toxic in the absence of light but they are activated by light of a wavelength corresponding to one of the absorption peaks from the compound. In its excited state the haematoporphyrin molecule can interact directly with molecular oxygen to generate singlet oxygen, or with a biomolecular substrate to generate free radicals (Boegheim, 1988; Gomer et al., 1988; Davila & Harriman, 1989) ; singlet oxygen has been identified as the most important damaging species. In vivo, the primary target appears to be the vascular endothelium, with secondary ischaemic cell death occurring as the result of vascular constriction and occlusion (e.g. Bugelski et al., 1981; Star et al., 1984; 1986; Henderson et al., 1985; Bown et al., 1986) .
Photodynamic therapy was first used for the treatment of human bladder cancer in 1976 (Kelly & Snell, 1976) but the efficacy of tumour destruction was limited by the light sources available at that time (transurethral illumination with white light). With the advent of fibre optics, transurethral illumination with laser light has become possible and PDT now appears to be a promising alternative to the use of transurethral resection (TUR) for the treatment of superficial bladder cancer, including carcinoma in situ, CIS (Hisazumi et al., 1983; Benson, 1985; Jocham, 1987 (Jocham, 1987 (Jocham et al., 1984; Jocham, 1987) or with the use of special isotropic light sources with a diffuser 'light bulb' tip (Benson, 1985; Nseyo et al., 1985; Star et al., 1987; Marijnissen et al., 1989 Light source and doses For illumination of the bladders, the anaesthetised mice were inverted with the catheter and fibre in position. Inversion served two purposes: (a) the intestine dropped downwards out of the illumination field, (b) the vertical alignment of the bladder increased the probability of correctly positioning the fibre in the centre of the bladder. The light delivery fibre was coupled to a 12 W argon laser (Spectra-Physics model 171), which powered a dye laser (Spectra-Physics model 375) tuned to 630 nm. A power setting of 100 mW was used and the output from the fibre tip was checked (in air) before and after each treatment with an integrating light sphere. The bladders were filled with 0.2 ml fluid prior to illumination therefore the calculated surface area of the bladder, assuming it to be a perfect sphere, should be 165 mm2. However, the bladder is not a perfect sphere and, moreover, small quantities of fluid often leaked during filling. In a representative sample of 18 mice (not used for the PDT experiments), the bladder was surgically exposed (under anaesthetic) after filling with 0.2 ml fluid and the actual size of the bladder was measured in 3 orthoganol diameters using fine vernier calipers. The surface area calculated from the geometric mean radius of these measurements was 134 ± 25 mm2 ( ± 1 s.d.). This area was used to calculate the incident light dose (i.e. for a fibre output of 100 mW this represents 75 mW cm-2 at the bladder surface). Illumination times ranged from 50 s to 4 min and 1O s, which is equivalent to 3.75 J cm-2 to 18.75 J cm-2. All light doses quoted from frequency index (spots per ml) and has been described in detail elsewhere (Stewart et al., 1978; Stewart 1986 
Results
Survival and weight loss In initial toxicity studies, small numbers of mice (three to four per dose group) were treated with light doses of up to 37.5 J cm-2 (using the plane cut off fibre) at 24 h after 10 mg kg-' Photofrin II. All mice in dose groups above 18.75 J cm-2 became clinically ill and were sacrificed over the period 2 to 9 days after treatment. At post mortem there was obvious swelling and erythema in the whole pubic area with evidence of fat necrosis in the immediate vicinity of the bladder. The bladders were haemorrhagic and oedema of the uterus and cervix was also seen. There was no sign of haemorrhage or necrosis of the intestine. All animals treated with 37.5 J cm-2 alone or Photofrin II alone remained healthy and without significant weight loss.
On the basis of initial toxicity studies, the maximum light dose delivered to the bladder was subsequently restricted to < 18.75 J cm-2 non scattered light. In the first experimental series, using the plane cut off fibre for light delivery, the LDM was 19.9 ± 3.2 J cm-2 ( ± 1 s.e.) for illumination of the bladder 24 h after 1Omg kg-' Photofrin. In the second experimental series using the diffuser bulb fibre for light delivery the LD50 was 15.7 ± 2.1 (Table I) This presumably reflected dehydration and general ill health of these mice, which were excluded from the frequency analysis since it seemed unlikely that the corresponding frequency index would reflect specific bladder damage.
Following PDT with the plane cut off fibre, there was a significant increase (P<0.4; Mann-Whitney two sample test) in the group mean frequency index after all light doses tested (4.7 to 14 J cm-2) at 1 to 2 weeks after treatment, with a return to control levels by 3 weeks after light doses of 4.7Jcm-2, and within 9 weeks after 9.4Jcm-2. There was also some recovery from 2 to 16 weeks after 14 J cm 2, but the urination frequency index remained above control levels for up to 25 weeks in some animals. The pattern and extent of functional bladder damage and recovery after PDT using the plane cut off fibre were essentially the same as for the isotropic diffuser bulb fibre. The major difference was that a greater variation between animals was seen using the plane cut off fibre and results from these experiments are therefore not discussed in detail.
In experiments using the diffuser bulb fibre for light delivery, there was a significant increase (P<0.04; MannWhitney two sample test) in the group mean urination frequency index at 1 week after PDT for all light doses and recovery to control levels within 2 to 6 weeks after doses of 3.75 to 7.5 J cm2 (Figure 2, top) . After higher doses the urination frequency index remained elevated for some animals until the end of the testing period, although, because of the large variation in response between animals, the mean frequency index was not significantly different from control. In the top dose group the mean urination frequency index is probably an underestimate of the amount of functional bladder damage induced, since four out of 11 mice died during the acute period (1 to 3 weeks) and at least one of the survivors at each subsequent test produced <0.5 ml urine/ 24h and was therefore excluded from the analysis. The results from urination frequency tests were also expressed as the percentage of mice with a frequency index of more than twice control (i.e. > 12 spots per ml). There was a 20% incidence of increased frequency at 1 week after light doses of 3.75 J cm-2 and a 70 to 100% incidence after doses of 7.5 to 13.1 J cm-2. By 10 weeks, only 20 to 50% of mice treated with light doses > 11.25 J cm-2 had an increased frequency (Figure 2, bottom) .
The dose response curves for mean urination frequency index and the incidence of increased frequency are shown in Figure 3 . There was a clear relationship between light dose and both the extent of functional bladder damage (mean frequency index, Figure 3 top) and percentage of mice with a 2-fold increase in frequency index (Figure 3 bottom) . Both the severity and incidence of damage were reduced at 14 weeks compared with 1 week.
The light dose required for a 2-fold increase in urination frequency index in 50% of the mice (ED50 ± ls.e.) was calculated by probit analysis at each testing time. In the acute phase (1 week), the ED50 was only 6.2 ± 1.0 J cm2). but there was good recovery from the PDT induced damage after low doses and the estimated ED50 for increased urination frequency at 10 weeks had increased to 16.8 ± 4.9 J cm2.
From 10 to 26 weeks there was no further change in the ED50 (Figure 4) . For and 14 weeks after PDT with the plane cut off fibre were 6.5 ± 1.7 and 17.2 ± 5.5 respectively (i.e. no significant difference between the two fibres).
Haematuria
Haematuria was seen in some animals from all dose groups during the first week after PDT and the incidence was dose related. Light alone or Photofrin II alone did not cause haematuria. In most cases haematuria did not persist beyond the first week but some responses were also seen at 2 to 4 weeks, and in the highest dose groups up to 25 weeks after PDT. The cumulative incidence of haematuria during the is shown in Table II . The ED50 for haematuria during the acute phase was 7.6 ± 1.0 J cm-2 for diffuser bulb fibre and 6.5 ± 2.3 for the plane cut off fibre (ED50 ± 1 s.e. calculated by probit analysis).
Histology
Urinary bladders of mice which had received only Photofrin II or bladder illumination were histologically identical to those of untreated control mice. The bladder surface was lined by a smooth or slightly folded layer of transitional epithelium, below which the lamina propria, consisting of a small amount of subendothelial loose connective tissue containing thin-walled vessels, was present. In some instances a muscularis mucosa could be discerned. This and the muscularis propria consisted of smooth muscle cells with a very small amount of collagen. Some specimens contained a small amount of adherent fatty tissue, some of which was of the 'brown' (multivacuolated) variety. One day after treatment, mice receiving Photofrin II and illumination exceeding 4.7 J cm-2 showed signs of acute damage, consisting of epithelial sloughing, oedema, fibrin extravasation, dilatation of blood vessels and, rarely, thrombosis (Figure 5a ). Most cases receiving 11.3 J cm-2 or more also exhibited areas of frank necrosis of the bladder wall. In some cases the toxic damage was complicated by bacterial infection, as evidenced by the presence of large colonies of bacteria, associated with a dense transmural polymorphonuclear inflammatory infiltrate ( Figure Sb Histological sections of mouse bladder at various intervals after PDT treatment. 5 lam sections, stained with haematoxalin Eosin, original magnification x 100. a, One day after PDT, 9.4 J cm-2. The surface epithelial layer is partially detached from the lamina propria (LP), which exhibits a mild degree of oedema and some fibrin extravasation. b, One week after PDT, 14.1 J cm2. There is focal necrosis of the mucosa (N), and a transmural inflammatory infiltrate (I) indicates acute damage also of deeper layers. c, Six months after PDT, 9.4 J cm-2. The histology is practically normal; there is a very slight degree of fibrosis of the lamina propria with pseudopapillary in foldings (P). d, Six months after PDT, 9.4 J cm2. Distinct fibrosis of the lamina propria (F) and a darkly-staining focus of calcification (C) within the muscle layer. (Figure 5c ). These late signs of damage tended to diminish with time; after 6 months, histological abnormalities were generally minimal, consisting mainly of a slight degree of fibrosis, although a few specimens (from mice treated with light doses > 9.4 J cm-2) had a more severe degree of fibrosis which extended into the muscle layer and which could be associated with calcification (Figure 5d ).
Discussion
Clinical interest in the use of photodynamic therapy as an alternative to TUR with chemotherapy for localised bladder cancer, particularly CIS, is increasing (Tsuchiya et al., 1983; Hisazumi et al., 1984; Benson, 1985; Jocham, 1987; Prout et al., 1987; Shumaker & Hetzel, 1987; Gomer et al., 1989 (Star et al., 1987) (Benson, 1985; Jocham, 1987; Harty et al., 1989) . Cystoscopy generally reveals oedema and an exudative reaction in the mucosa. However, in many cases the reactions are reported as transient with a return to near normal bladder function within 3 to 5 months (Benson, 1985; Jocham, 1987) . Another, more serious, possible side effect of bladder PDT is vesicouretic reflux and hydronephrosis, which can develop as a result of decreased bladder capacity and ureteral obstruction .
The purpose of our study was to measure the extent and duration of functional damage and recovery in normal mouse bladder after PDT with a range of light doses given 1 day after 10mg kg-' Photofrin II. Our results demonstrated that increased frequency and haematuria occurred during the first month after treatment, even with modest incident light doses (3.75 to 7.5 J cm-2), but that the severe acute reaction was transient, with partial or complete recovery (depending on the light dose) within 5 to 10 weeks. Bladder functional damage during the acute phase coincided with a histological picture of submucosal oedema and inflammation with epithelial sloughing. During the acute phase it is likely that bacterial infection of the partly denuded bladder mucosa also contributed to the observed increase in urination frequency. Animals in the present study were not tested for the presence of bacteria in the urine but bacterial colonies were visible in the mucosa of some histology specimens taken during the first 2 weeks after PDT with high light doses. In a separate series of mice (unpublished data), the urine was tested for the presence of nitrates after PDT and nearly all mice treated with 10 J cm2 plus Photofrin were positive during the first month, whereas animals treated with light or Photofrin II alone were negative. Bacterial infection will contribute to any inflammation of the bladder wall and oedema and antibiotics given after PDT could help to limit the acute reactions. Studies are currently underway to investigate this in our mouse bladder model. We noted an occasional incidence of cyst formation in the kidneys of PDT treated mice and, in one case, a histologically confirmed advanced pyelonephritis. This may well have been the result of an ascending urinary tract infection, but ureteral blockage (caused by oedema and fibrosis) with back pressure may also have played a role. Since the kidneys were not routinely taken for histology a higher incidence of renal complication may have occurred but gone undetected in our experiments.
Despite a severe acute reaction after PDT, the long term recovery was good and there was only minimal persistent functional damage (increased urination frequency and haematuria) after light doses up to 9.4 J cm-2. Some submucosal fibrosis was seen at 6 months along with mild vascular damage and pseudopapillary infoldings which may have been the result of excessive oedema during the acute phase and subsequent contraction of the bladder.
There have been very few published reports of the effects of PDT in normal bladder tissue using experimental animal models (Nseyo et al., 1985; Reed et al., 1989; Pope & Bown, 1991) . Nseyo et al. (1985) treated dog bladders with intravesical PDT and examined the tissue histologically at 5 days after treatment. Whole bladder exposure of light alone (30 J cm2) produced a slight, generalised oedema in the epithelium. Light doses of 30 J CM-2 given 3 days after Photofrin II caused oedema and multiple superficial ulcers. Haemorrhage was also observed in the lamina propria, together with focal damage to the muscle layer. No specimens were available of bladders at longer intervals than 5 days, so it is not possible to assess the long term effects of PDT from this study.
Another study followed the microvascular changes in the rat bladder during the first hour after PDT (Reed et al., 1989) . Significant reductions in the red blood cell column diameters of arterioles and venules were found, with evidence of thrombus formation and blood flow stasis. The vascular changes were much more marked when light (105 J cm-2) was applied at 30 min after Photofrin II than at 2 days. The authors concluded that for intervals of 48 h or longer between sensitiser and light any damage to the normal bladder was the result of diret photosensitisation in the bladder wall, whereas the shorter intervals lead to preferential microvascular damage.
The only other study of functional changes in the normal bladder after PDT was reported by Pope and Bown (1991) , who studied compliance in the rat bladder for up to 3 months after PDT. In these studies, chloraluminium sulphonated phthalocyanine was used as the photosensitiser and 20 J cm2 red light (675 nm) was delivered intravesically after 24 h. The treated rats had an initial reduction in bladder capacity but recovery was rapid (within 2 weeks) after low sensitiser doses (0.5 mg kg-'). Recovery was much slower after sensitiser doses of 1.5 mg kg-' combined with 20 JCcm2, and some reduced bladder capacity was still evident at 3 months. These results agree well with those obtained in the present study and suggest that a severe acute response occurs after whole bladder PDT which involves epithelial denudation and submucosal oedema, associated with increased urination frequency and reduced bladder capacity. Providing tolerance limits of light and sensitiser dose are not exceeded, however, the acute damage heals rapidly to leave a functional bladder with minimal histological changes within 2 to 3 months of treatment. From our results with the mouse bladder 'tolerance' is estimated at about 10 J cm-2 non scattered light for whole bladder illumination at 24 h after 10 mg kg-' Photofrin II. This would correspond to absorbed light doses of approximately 35 to 45Jcm-2.
